Tengion Provides Clinical Update and Reports Third Quarter 2014 Financial Results and Cash Position
November 14, 2014 16:01 ET
|
Tengion, Inc.
WINSTON-SALEM, N.C., Nov. 14, 2014 (GLOBE NEWSWIRE) -- Tengion, Inc. (OTCQB:TNGN), a leader in regenerative medicine, today reported key clinical data along with financial and operating results for...
Tengion Retains Jefferies to Explore Strategic Options for the Company
September 22, 2014 08:00 ET
|
Tengion, Inc.
WINSTON-SALEM, N.C., Sept. 22, 2014 (GLOBE NEWSWIRE) -- Tengion, Inc. (OTCQB:TNGN), a leader in regenerative medicine, today announced that the Company, with the support of its Board of Directors, is...
Tengion Provides Clinical Update and Reports Second Quarter 2014 Financial Results
August 13, 2014 12:31 ET
|
Tengion, Inc.
WINSTON-SALEM, N.C., Aug. 13, 2014 (GLOBE NEWSWIRE) -- Tengion, Inc. (OTCQB:TNGN), a leader in regenerative medicine, today reported key clinical data along with financial and operating results for...
Tengion Reports First Quarter 2014 Financial Results
May 15, 2014 16:05 ET
|
Tengion, Inc.
WINSTON-SALEM, N.C., May 15, 2014 (GLOBE NEWSWIRE) -- Tengion, Inc. (OTCQB:TNGN), a leader in regenerative medicine, today reported its financial results for the first quarter ended March 31,...
Tengion Reports Fourth Quarter and Full Year 2013 Financial Results
March 26, 2014 16:05 ET
|
Tengion, Inc.
WINSTON-SALEM, N.C., March 26, 2014 (GLOBE NEWSWIRE) -- Tengion, Inc. (OTCQB:TNGN), a leader in regenerative medicine, today reported its financial results for the fourth quarter and full year ended...
Tengion to Present at the 26th Annual ROTH Conference
March 04, 2014 16:30 ET
|
Tengion, Inc.
WINSTON-SALEM, N.C., March 4, 2014 (GLOBE NEWSWIRE) -- Tengion, Inc. (OTCQB:TNGN), a leader in regenerative medicine, today announced that John L. Miclot, President and Chief Executive Officer of...
Tengion Announces Continued Clinical Progress in Its Two Lead Programs
January 13, 2014 09:00 ET
|
Tengion, Inc.
-- Expansion Planned for Neo-Kidney Augment™ Swedish Phase 1 Clinical Trial to Include Ten Additional Patients; U.S. Phase 1 Clinical Trial Initiated --
-- Neo-Urinary Conduit™ U.S....